ArticleNeoplasia (New York, N.Y.)2011

Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.

Ulrike Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.